SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: former_pgs who wrote (3653)12/15/2005 9:44:03 PM
From: rkrw  Read Replies (1) | Respond to of 12215
 
My understanding is the nvs royalties are "double digit." To be safe, I'm using 10%. But they could be a little better.

I think the Roche compounds are now speedel's free and clear.



To: former_pgs who wrote (3653)12/15/2005 10:14:43 PM
From: rkrw  Read Replies (1) | Respond to of 12215
 
pgs, forget to mention the 600 series is internally developed. But I guess you don't think that's such a good thing :-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News